MANMOHAN, NAJMI WAZIRI
Union Of India – Appellant
Versus
Panacea Biotec Limited – Respondent
JUDGMENT :
MANMOHAN, J.
C.M.No. 16526/2021
1. Present application has been heard by way of video conferencing.
FACTS
2. The present appeal has been filed by the Appellant challenging the judgment and order dated 18th March, 2020, passed by learned Single Judge whereby the application filed by the Appellant herein under Section 34 of the Arbitration and Conciliation Act 1996 (hereinafter referred to as “the Act 1996”) was rejected on the ground of delay terming it as merely a ‘bunch of papers’ and that by the time it was re-filed along with a copy of the Award, the period of limitation had expired, although the initial application had been filed with the registry within the period of limitation.
3. On 22nd July, 2020, learned counsel for the Respondent-Applicant had stated that the Respondent-Applicant, in the meantime, would not prosecute the execution proceedings instituted by it before the learned Single Judge.
4. Subsequently, present application being CM Appl.16526/2021 was filed by the Respondent-Applicant seeking modification of the interim order dated 22nd July, 2020 as well as for a direction to the Appellant to release the awarded amount along with interest to the Respondent-Appl
Interim order modified - It is settled law Court always has power to vary or modify any interim order for good and cogent reason. Respondent-Applicant had made a voluntary statement that in meantime;....
The court asserted the need for government accountability in drug distribution and ordered comprehensive reporting on the supply capabilities of Tocilizumab amid urgent demand due to COVID-19.
The central legal point established in the judgment is the uncertainty in the further imports of Tocilizumab to India and the efforts made by Roche India to import and supply the drug, as well as the....
During a national emergency, the government can exercise powers under the Patents Act to ensure the availability of essential drugs, emphasizing public health needs amid a pandemic.
Court emphasizes urgency and coordinated efforts to ensure availability of critical medicine for COVID-19 patients while addressing broader supply chain issues.
The main legal point established is the need for immediate availability of essential drugs, such as Tocilizumab, for critically ill COVID-19 patients and the provisions of the Patents Act allowing fo....
Court mandates government engagement to enhance drug supply for COVID-19 patients, emphasizing transparency and efficiency in distribution amidst a health crisis.
The court emphasized that under Section 9 of the Arbitration Act, it can grant mandatory injunctions when there is a strong prima facie case and balance of convenience favors the petitioner, especial....
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.